Literature DB >> 20852300

Impact of intracranial extension on survival in stage IV nasopharyngeal carcinoma: identification of a subset of patients with better prognosis.

Yu-Chang Hu1, Ching-Hsiung Chang, Chien-Hsun Chen, Luo-Ping Ger, Wen-Shan Liu, Li-Ching Lin, Chung-Man Leung, Kuo-Chen Chang.   

Abstract

OBJECTIVE: T-stage is an imperfect prognostic indicator for patients with nasopharyngeal carcinoma. We evaluated the effect of extent of intracranial involvement on survival after conventional radiotherapy in patients with Stage T4 nasopharyngeal carcinoma.
METHODS: We conducted a retrospective analysis of the results of computed tomography, magnetic resonance imaging and treatment outcomes in 84 consecutive patients with Stage T4 nasopharyngeal carcinoma during the period September 1993 to December 2002 in Taiwan. The patients were subcategorized into those who had limited intracranial involvement (primary nasopharyngeal tumors with involvement of the unilateral cavernous sinus or the parasellar region only) or extensive involvement (extension of the tumors to the bilateral cavernous sinus or the parasellar region, into the orbit and the ethmoid sinus anteriorly, or to the prepontine region and the posterior cranial fossa).
RESULTS: Extensive intracranial involvement was found in 51.2% of the patients. Among these patients, the 5-year rate of overall survival after conventional radiotherapy was only 3.4%. In contrast, the 5-year survival among patients with limited intracranial involvement was 42.9%. This difference was significant (P < 0.001). In the multivariate analysis, extensive intracranial involvement, advanced age and a nodal status of N3 correlated with poor overall survival (all P < 0.05).
CONCLUSIONS: Among patients with T4 nasopharyngeal carcinoma, better treatment outcomes were associated with limited intracranial involvement. We conclude that a subdivision of Stage T4 nasopharyngeal carcinoma disease based on the extent of intracranial involvement would provide better prognostic information.

Entities:  

Mesh:

Year:  2010        PMID: 20852300     DOI: 10.1093/jjco/hyq171

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma. Treatment results and locoregional recurrence.

Authors:  J L-Y Chen; Y-S Huang; S-H Kuo; Y-F Chen; R-L Hong; J-Y Ko; P-J Lou; C-L Tsai; W-Y Chen; C-W Wang
Journal:  Strahlenther Onkol       Date:  2013-10-27       Impact factor: 3.621

2.  Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.

Authors:  Caineng Cao; Jingwei Luo; Li Gao; Junlin Yi; Xiaodong Huang; Suyan Li; Jianping Xiao; Zhong Zhang; Guozhen Xu
Journal:  Cancer Res Treat       Date:  2016-08-24       Impact factor: 4.679

3.  Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era.

Authors:  Sarbani Ghosh-Laskar; Avinash Pilar; Carlton Johnny; Kumar Prabhash; Amit Joshi; Jai Prakash Agarwal; Tejpal Gupta; Ashwini Budrukkar; Vedang Murthy; Monali Swain; Vanita Noronha; Vijay Maruthi Patil; Prathamesh Pai; Deepa Nair; Devendra Arvind Chaukar; Shivakumar Thiagarajan; Gouri Pantvaidya; Anuja Deshmukh; Pankaj Chaturvedi; Sudhir Nair; Anil D'Cruz
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-04-03

4.  Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system.

Authors:  P-Y OuYang; Z Su; X-H Ma; Y-P Mao; M-Z Liu; F-Y Xie
Journal:  Br J Cancer       Date:  2013-10-22       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.